Keppra
NDC 50474-002, levetiracetam, injection, solution, concentrate, from UCB, Inc..
- Product NDC
- 50474-002
- Status
- Listed
- Labeler
- UCB, Inc.
- Dosage form
- INJECTION, SOLUTION, CONCENTRATE
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA021872
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50474-002 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LEVETIRACETAM100 mg/mL
Pharmacologic classes
Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50474-002-63 | 50474000263 | 10 VIAL, SINGLE-USE in 1 CARTON (50474-002-63) / 5 mL in 1 VIAL, SINGLE-USE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/c6d5784d-abf9-45fe-ac5a-d5c53bd50f7eMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=50474-002
Use it
Look up 50474-002 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50474-002 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50474-002. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.